Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development

Figure 2

Tumor antigens related with prognosis in LIHC. (a) 763 high expressed and mutated potential tumor antigens in LIHC, and 4 candidates significantly related with survival. (b–e) Overall survival of LIHC patients stratified on the basis of (b) PES1, (c) MCMC3, (d) PPM1G, and (e) KPNA2 expression levels.

(a)

(b)

(c)

(d)

(e)